Related Experiment Videos
Can chemotherapy replace radiotherapy in low-grade gliomas? Time for randomized studies
1Department of Neurology/Neuro-Oncology Unit, Daniel den Hoed Cancer Center, PO Box 5201, 3008AE, Rotterdam, The Netherlands.
Seminars in Oncology
|February 7, 2004
Summary
Chemotherapy shows promise for treating low-grade gliomas, inducing responses and stabilizing disease. Further research is needed to confirm if chemotherapy can replace radiotherapy for these brain tumors.
Area of Science:
- Neuro-oncology
- Clinical Neurology
- Cancer Treatment Research
Background:
- Surgery and radiotherapy have been standard treatments for low-grade gliomas for 30 years, lacking robust trial evidence.
- Advances in understanding tumor chemosensitivity and temozolomide approval have increased interest in chemotherapy for low-grade gliomas.
Purpose of the Study:
- To review the emerging role of chemotherapy in treating low-grade gliomas.
- To assess the efficacy and potential of chemotherapy as an alternative to radiotherapy.
Main Methods:
- Review of phase II studies investigating chemotherapy for low-grade gliomas.
- Discussion of challenges in response assessment and patient selection.
- Mention of ongoing randomized controlled trials.
Main Results:
- Phase II studies indicate chemotherapy can achieve clinically relevant responses and disease stabilization in low-grade gliomas.
- Oligodendrogliomas show sensitivity to chemotherapy, with responses also observed in astrocytic tumors.
- Results from limited sample sizes suggest chemotherapy's potential, but require validation.
Conclusions:
- Chemotherapy demonstrates promising results in low-grade gliomas, including oligodendroglioma and astrocytic tumors.
- Further randomized controlled studies are essential to determine the clinical significance of observed responses and progression.
- The potential for chemotherapy to replace radiotherapy in low-grade glioma treatment is under investigation.